KIDINS220 and melanoma: Accumulated evidences have indicated that KIDINS220/ARMS could phosphorylate and sustain ERK signaling in different types of cells, such as neurons, lymphocytes, and melanoma cells (Ni et al., 2013; Fiala et al., 2015; Lopez-Menendez et al., 2019).